Ira R Hatton
Examiner (ID: 11187)
Most Active Art Unit | 3732 |
Art Unit(s) | 3736, 3739, 3732 |
Total Applications | 37 |
Issued Applications | 36 |
Pending Applications | 0 |
Abandoned Applications | 1 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 18449553
[patent_doc_number] => 20230190829
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-22
[patent_title] => COMPOSITION FOR DIAGNOSIS AND TREATMENT OF ALCOHOLIC LIVER DISEASE, USING CHANGE IN SHORT-CHAIN FATTY ACID PRODUCING GUT BACTERIAL COMMUNITY
[patent_app_type] => utility
[patent_app_number] => 18/050091
[patent_app_country] => US
[patent_app_date] => 2022-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12522
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18050091
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/050091 | Composition for diagnosis and treatment of alcoholic liver disease, using change in short-chain fatty acid producing gut bacterial community | Oct 26, 2022 | Issued |
Array
(
[id] => 18345923
[patent_doc_number] => 20230134033
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-04
[patent_title] => IMMUNOGENIC COMPLEX FOR ELICITING PROTECTIVE IMMUNITY AGAINST GROUP B STREPTOCOCCUS
[patent_app_type] => utility
[patent_app_number] => 18/048148
[patent_app_country] => US
[patent_app_date] => 2022-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8450
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18048148
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/048148 | IMMUNOGENIC COMPLEX FOR ELICITING PROTECTIVE IMMUNITY AGAINST GROUP B STREPTOCOCCUS | Oct 19, 2022 | Pending |
Array
(
[id] => 18449650
[patent_doc_number] => 20230190926
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-22
[patent_title] => METHODS OF PRODUCING BIOCONJUGATES OF E. COLI O-ANTIGEN POLYSACCHARIDES, COMPOSITIONS THEREOF, AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/938454
[patent_app_country] => US
[patent_app_date] => 2022-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38687
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17938454
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/938454 | METHODS OF PRODUCING BIOCONJUGATES OF E. COLI O-ANTIGEN POLYSACCHARIDES, COMPOSITIONS THEREOF, AND METHODS OF USE THEREOF | Oct 5, 2022 | Pending |
Array
(
[id] => 18308797
[patent_doc_number] => 20230112697
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-13
[patent_title] => METHODS AND COMPOSITIONS RELATED TO THE NEXT GENERATION VACCINE
[patent_app_type] => utility
[patent_app_number] => 17/931356
[patent_app_country] => US
[patent_app_date] => 2022-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26635
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17931356
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/931356 | METHODS AND COMPOSITIONS RELATED TO THE NEXT GENERATION VACCINE | Sep 11, 2022 | Pending |
Array
(
[id] => 18145632
[patent_doc_number] => 20230019488
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-19
[patent_title] => NEISSERIA MENINGITIDIS IMMUNOGENIC COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 17/929415
[patent_app_country] => US
[patent_app_date] => 2022-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19307
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17929415
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/929415 | NEISSERIA MENINGITIDIS IMMUNOGENIC COMPOSITIONS | Sep 1, 2022 | Pending |
Array
(
[id] => 18091373
[patent_doc_number] => 20220409714
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-29
[patent_title] => Protection from Stress, Anxiety, Neuroinflammation, and Cognitive Dysfunction
[patent_app_type] => utility
[patent_app_number] => 17/821354
[patent_app_country] => US
[patent_app_date] => 2022-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19668
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17821354
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/821354 | Protection from stress, anxiety, neuroinflammation, and cognitive dysfunction | Aug 21, 2022 | Issued |
Array
(
[id] => 18497421
[patent_doc_number] => 20230220055
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-13
[patent_title] => ANTIBODIES TARGETING A GALACTAN-BASED O-ANTIGEN OF K. PNEUMONIAE
[patent_app_type] => utility
[patent_app_number] => 17/820082
[patent_app_country] => US
[patent_app_date] => 2022-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26491
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17820082
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/820082 | ANTIBODIES TARGETING A GALACTAN-BASED O-ANTIGEN OF K. PNEUMONIAE | Aug 15, 2022 | |
Array
(
[id] => 18184777
[patent_doc_number] => 20230045507
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-09
[patent_title] => Chimeric proteins for inducing immunity towards infection with S. aureus
[patent_app_type] => utility
[patent_app_number] => 17/816145
[patent_app_country] => US
[patent_app_date] => 2022-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43162
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 256
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17816145
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/816145 | Chimeric proteins for inducing immunity towards infection with S. aureus | Jul 28, 2022 | Pending |
Array
(
[id] => 18404599
[patent_doc_number] => 20230165950
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-01
[patent_title] => IMMUNOGENIC COMPOSITION COMPRISING CYAA-DERIVED POLYPEPTIDE PROMOTING A TH1/TH17-ORIENTED IMMUNE RESPONSE
[patent_app_type] => utility
[patent_app_number] => 17/814988
[patent_app_country] => US
[patent_app_date] => 2022-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16697
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 123
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17814988
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/814988 | IMMUNOGENIC COMPOSITION COMPRISING CYAA-DERIVED POLYPEPTIDE PROMOTING A TH1/TH17-ORIENTED IMMUNE RESPONSE | Jul 25, 2022 | Pending |
Array
(
[id] => 18195537
[patent_doc_number] => 20230049056
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-16
[patent_title] => FimH mutant, compositions therewith and use thereof
[patent_app_type] => utility
[patent_app_number] => 17/814966
[patent_app_country] => US
[patent_app_date] => 2022-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11308
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17814966
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/814966 | FimH mutant, compositions therewith and use thereof | Jul 25, 2022 | Issued |
Array
(
[id] => 18056441
[patent_doc_number] => 20220387527
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-08
[patent_title] => USE OF LACTIC ACID BACTERIA TO TREAT OR PREVENT GESTATIONAL DIABETES MELLITUS
[patent_app_type] => utility
[patent_app_number] => 17/813233
[patent_app_country] => US
[patent_app_date] => 2022-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13487
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17813233
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/813233 | USE OF LACTIC ACID BACTERIA TO TREAT OR PREVENT GESTATIONAL DIABETES MELLITUS | Jul 17, 2022 | Pending |
Array
(
[id] => 18126560
[patent_doc_number] => 20230012181
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-12
[patent_title] => TREATMENT OF ACUTE AND CHRONIC KIDNEY DISEASE
[patent_app_type] => utility
[patent_app_number] => 17/862295
[patent_app_country] => US
[patent_app_date] => 2022-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9832
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17862295
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/862295 | Treatment of acute and chronic kidney disease | Jul 10, 2022 | Issued |
Array
(
[id] => 17836477
[patent_doc_number] => 20220273782
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-01
[patent_title] => Novel PD-L1 Targeting DNA Vaccine for Cancer Immunotherapy
[patent_app_type] => utility
[patent_app_number] => 17/730909
[patent_app_country] => US
[patent_app_date] => 2022-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9856
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17730909
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/730909 | Novel PD-L1 Targeting DNA Vaccine for Cancer Immunotherapy | Apr 26, 2022 | Abandoned |
Array
(
[id] => 17760063
[patent_doc_number] => 20220233675
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-28
[patent_title] => VACCINE TO PROTECT A PIG AGAINST ACTINOBACILLUS PLEUROPNEUMONIAE
[patent_app_type] => utility
[patent_app_number] => 17/721115
[patent_app_country] => US
[patent_app_date] => 2022-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3356
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17721115
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/721115 | VACCINE TO PROTECT A PIG AGAINST ACTINOBACILLUS PLEUROPNEUMONIAE | Apr 13, 2022 | Pending |
Array
(
[id] => 19256861
[patent_doc_number] => 12016890
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-06-25
[patent_title] => Composition for preventing or treating menopause, containing
[patent_app_type] => utility
[patent_app_number] => 17/714361
[patent_app_country] => US
[patent_app_date] => 2022-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 9589
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17714361
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/714361 | Composition for preventing or treating menopause, containing | Apr 5, 2022 | Issued |
Array
(
[id] => 17733315
[patent_doc_number] => 20220218774
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-14
[patent_title] => METHOD FOR TREATING A SKIN WOUND HAVING A KLEBSIELLA PNEUMONIAE INFECTION
[patent_app_type] => utility
[patent_app_number] => 17/707132
[patent_app_country] => US
[patent_app_date] => 2022-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16953
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17707132
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/707132 | Method for treating a skin wound having a | Mar 28, 2022 | Issued |
Array
(
[id] => 17748252
[patent_doc_number] => 20220226455
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-21
[patent_title] => VACCINE AGAINST NECROTIC ENTERITIS IN POULTRY
[patent_app_type] => utility
[patent_app_number] => 17/705913
[patent_app_country] => US
[patent_app_date] => 2022-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10563
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 130
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17705913
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/705913 | VACCINE AGAINST NECROTIC ENTERITIS IN POULTRY | Mar 27, 2022 | Pending |
Array
(
[id] => 18503605
[patent_doc_number] => 11701395
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-07-18
[patent_title] => Food composition and pharmaceutical composition for inhibiting Sjogren's syndrome each containing
[patent_app_type] => utility
[patent_app_number] => 17/574399
[patent_app_country] => US
[patent_app_date] => 2022-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 14
[patent_no_of_words] => 5531
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17574399
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/574399 | Food composition and pharmaceutical composition for inhibiting Sjogren's syndrome each containing | Jan 11, 2022 | Issued |
Array
(
[id] => 17734700
[patent_doc_number] => 20220220159
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-14
[patent_title] => FIMH MUTANTS, COMPOSITIONS THEREWITH AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/573249
[patent_app_country] => US
[patent_app_date] => 2022-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12928
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17573249
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/573249 | FimH mutants, compositions therewith and use thereof | Jan 10, 2022 | Issued |
Array
(
[id] => 17580192
[patent_doc_number] => 20220137047
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-05
[patent_title] => BORRELIA IMMUNOASSAYS AND MATERIALS THEREFOR
[patent_app_type] => utility
[patent_app_number] => 17/562055
[patent_app_country] => US
[patent_app_date] => 2021-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11613
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17562055
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/562055 | BORRELIA IMMUNOASSAYS AND MATERIALS THEREFOR | Dec 26, 2021 | Pending |